Home›Stock Screener›Shelter Pharma›Financial Statements

Shelter Pharma Complete Financial Statements

8 Years of Data
2026 - 2017

In FYNone, Shelter Pharma (SHELTER) reported revenue ₹0 Cr, net profit ₹0 Cr and EPS ₹0.00, with a net profit margin of 12.3% and ROE of 11.7%. Full financial statements from FY2017 to FY2026 (8 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see Shelter Pharma share price chart.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 12.33% 2026 data
EBITDA Margin 17.81% 2026 data
Operating Margin 17.00% 2026 data
Return on Assets 10.71% 2026 data
Return on Equity 11.69% 2026 data

Balance Sheet Ratios

Current Ratio 55.00 2026 data
Equity Ratio 91.67% 2026 data
Asset Turnover 0.87 2026 data

SHELTER Revenue, Net Profit & EBITDA — Year-on-Year Growth

SHELTER YoY (March 2026 vs Period) — revenue -100.0%, net profit -100.0%, EBITDA -100.0%, expenses -100.0%. Compare with SHELTER DCF valuation to assess whether the stock is under or overvalued.

Revenue Growth
-100.0%
Year-over-Year
Net Profit Growth
-100.0%
Year-over-Year
EBITDA Growth
-100.0%
Year-over-Year
Expense Growth
-100.0%
Year-over-Year
Assets Growth
+75.0%
Year-over-Year
Equity Growth
+79.1%
Year-over-Year
Operating Cash Flow Growth
-360.0%
Year-over-Year
Investing Cash Flow Growth
-114.3%
Year-over-Year

SHELTER Income Statement — Revenue, EBITDA & Net Profit

Shelter Pharma revenue ₹0 Cr, EBITDA ₹0 Cr, net profit ₹0 Cr, EPS ₹0.00 (None) — net profit margin 12.3%.

Periods ₹ Crores
Particulars None March 2026 March 2025 March 2024 March 2023 March 2022 March 2021 March 2020
Revenue 0 73 51 40 36 30 23 30
Expenses 0 60 41 32 28 27 22 30
EBITDA 0 13 10 9 8 3 0 0
Operating Profit Margin % 0.00% 17.00% 20.00% 21.00% 22.00% 10.00% 1.00% 1.00%
Depreciation 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0
Profit Before Tax 0 12 10 8 7 3 0 0
Tax 0 3 2 2 2 1 0 0
Net Profit 0 9 7 6 5 2 0 0
Earnings Per Share (₹) 0.00 6.57 6.26 5.36 6.72 42.54 0.88 1.77

SHELTER Balance Sheet — Assets, Liabilities & Shareholders' Equity

SHELTER total assets ₹84 Cr, total equity ₹77 Cr, total liabilities ₹ Cr (2026) — ROE 11.7%.

Years Annual Data ₹ Crores
Particulars 2026 2025 2024 2023 2022 2021 2020
ASSETS
Total Assets 84 48 38 21 13 10 11
Current Assets 55 33 30 19 10 8 8
Fixed Assets 7 6 4 2 2 2 2
Capital Work in Progress 0 0 0 0 1 0 0
Investments 0 0 0 0 0 0 0
Other Assets 77 42 34 20 11 9 9
LIABILITIES
Total Liabilities
Current Liabilities 1 1 1 1 0 0 0
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 77 43 36 15 9 7 7
Share Capital 17 12 12 8 1 1 1
Reserves & Surplus 56 31 24 7 8 7 7

SHELTER Cash Flow Statement — Operating, Investing & Financing

Shelter Pharma operating cash flow ₹-13 Cr, investing ₹-15 Cr, financing ₹25 Cr, net cash flow ₹-2 Cr (2026).

Periods ₹ Crores
Particulars March 2026 March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2017
Operating Activities -13 5 -2 0 1 0 0 0
Investing Activities -15 -7 -4 0 -1 0 0 0
Financing Activities 25 0 11 0 0 1 0 0
Net Cash Flow -2 -2 5 0 0 0 0 0